Connection
Danielle Cooke to Sclerosing Solutions
This is a "connection" page, showing publications Danielle Cooke has written about Sclerosing Solutions.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.258 |
|
|
|
-
Hirabayashi KE, Kalin-Hajdu E, Bever GJ, Vagefi MR, de Alba Campomanes AG, Cooke DL, Dowd CF, Kersten RC. Normalization of Congenital Venous Stasis Retinopathy Following Sclerotherapy of a Macrocystic Lymphatic Malformation. Ophthalmic Plast Reconstr Surg. 2018 Jan/Feb; 34(1):e19-e21.
Score: 0.152
-
Caton MT, Duvvuri M, Baker A, Smith ER, Narsinh KH, Amans MR, Hetts SW, Higashida RT, Cooke DL, Dowd CF. Percutaneous sclerotherapy for head and neck lymphatic malformations in neonates and infants =12 months of age. J Neurointerv Surg. 2023 Dec; 15(12):1242-1246.
Score: 0.053
-
Caton MT, Baker A, Smith ER, Perez E, Hemphill K, Cooke DL, Dowd CF. Dual-agent percutaneous sclerotherapy technique for macrocystic lymphatic malformations. J Neurointerv Surg. 2023 Sep; 15(9):931.
Score: 0.052